{"id":417715,"date":"2021-01-20T08:26:15","date_gmt":"2021-01-20T13:26:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=417715"},"modified":"2021-01-20T08:26:15","modified_gmt":"2021-01-20T13:26:15","slug":"ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/","title":{"rendered":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">New York, NY, Jan.  20, 2021  (GLOBE NEWSWIRE) &#8212; IR-Med, Inc, (OTC: IRME) (the \u201cCompany\u201d or \u201cIR-Med\u201d) announced today that the Financial Industry Regulatory Authority, Inc. (\u201cFINRA\u201d) has approved the Company\u2019s name change to \u201cIR Med, Inc.\u201d (from International Display Advertising, Inc.) and changed its ticker symbol to \u201cIRME\u201d. These corporate actions will be effective as of the open of trading on January 20, 2021. The new CUSIP number for the common stock will be 46265R103. \u00a0These changes follow the Company\u2019s announcement, in December 2020, of the successful completion of a share exchange transaction with I.R Med Ltd., an Israeli company, pursuant to which I.R Med Ltd became a wholly-owned subsidiary of the Company.<\/p>\n<p align=\"justify\">Commenting on the actions, Limor Davidson Mund, Chief Executive Officer of the Company, stated: \u201cThese changes represent a deliberate and strategic rebranding effort. We are excited to now be operating under a name that is reflective of our core business\u201d.<\/p>\n<p>\n        <strong>About the IR-Med<\/strong>\n      <\/p>\n<p align=\"justify\">IR-Med is a development stage company currently focused on the development and application of Infra-Red (IR) and Artificial Intelligence (AI) technologies to address common medical ailments. Initially I.R Med\u2019s technologies are designed to address the early detection of pressure injuries (PI) and the detection and diagnosis of ear infection, primarily in children.\u00a0For more information visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dVNpfrpbGZPQAnSR57g_M7IJ4tbsn3QFHTZ0tplA4de4baNj4U_JkRxEvJX0ZZAM3P2FIj4D_3syumJVsB2kfjGFXELRAaupcD2SDX8q7sY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>http:\/\/www.ir-medical.com<\/u><\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <em>Forward Looking Statements<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to novel technologies and methods; our business and product development plans; or market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, our ability to raise the additional funding we will need to continue to pursue our business plan and product development plans; the inherent uncertainties associated with developing new products or technologies and operating as a development stage company; our ability to develop, complete clinical trials and obtain approvals for the commercialization of any of our product candidates; competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. <\/em><br \/>\n        <em>\u00a0<\/em><br \/>\n        <em>The Company does not undertake any obligation to publicly update any forward looking statement. The Company is not subject to the reporting requirements of the Securities and Exchange Commission under the Securities and Exchange Act of 1934 as amended<\/em>.<\/p>\n<p>Company Contact:\u00a0<\/p>\n<p>Limor Davidson Mund<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6fFfrOdzBEowdUTq1QEbKWZFrDDEVhQKXwViOq27g9OABrotIH0vVNNtwWF8_6sMJzFvHoxvaqrNrEcpPX9iww==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>ir@ir-medical.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c6b0534f-8f14-4bdd-b16a-4c701cb6f398\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>New York, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; IR-Med, Inc, (OTC: IRME) (the \u201cCompany\u201d or \u201cIR-Med\u201d) announced today that the Financial Industry Regulatory Authority, Inc. (\u201cFINRA\u201d) has approved the Company\u2019s name change to \u201cIR Med, Inc.\u201d (from International Display Advertising, Inc.) and changed its ticker symbol to \u201cIRME\u201d. These corporate actions will be effective as of the open of trading on January 20, 2021. The new CUSIP number for the common stock will be 46265R103. \u00a0These changes follow the Company\u2019s announcement, in December 2020, of the successful completion of a share exchange transaction with I.R Med Ltd., an Israeli company, pursuant to which I.R Med Ltd became a wholly-owned subsidiary of the Company. Commenting on the actions, Limor Davidson &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-417715","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"New York, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; IR-Med, Inc, (OTC: IRME) (the \u201cCompany\u201d or \u201cIR-Med\u201d) announced today that the Financial Industry Regulatory Authority, Inc. (\u201cFINRA\u201d) has approved the Company\u2019s name change to \u201cIR Med, Inc.\u201d (from International Display Advertising, Inc.) and changed its ticker symbol to \u201cIRME\u201d. These corporate actions will be effective as of the open of trading on January 20, 2021. The new CUSIP number for the common stock will be 46265R103. \u00a0These changes follow the Company\u2019s announcement, in December 2020, of the successful completion of a share exchange transaction with I.R Med Ltd., an Israeli company, pursuant to which I.R Med Ltd became a wholly-owned subsidiary of the Company. Commenting on the actions, Limor Davidson &hellip; Continue reading &quot;IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T13:26:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d\",\"datePublished\":\"2021-01-20T13:26:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/\"},\"wordCount\":477,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/\",\"name\":\"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\",\"datePublished\":\"2021-01-20T13:26:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/","og_locale":"en_US","og_type":"article","og_title":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk","og_description":"New York, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) &#8212; IR-Med, Inc, (OTC: IRME) (the \u201cCompany\u201d or \u201cIR-Med\u201d) announced today that the Financial Industry Regulatory Authority, Inc. (\u201cFINRA\u201d) has approved the Company\u2019s name change to \u201cIR Med, Inc.\u201d (from International Display Advertising, Inc.) and changed its ticker symbol to \u201cIRME\u201d. These corporate actions will be effective as of the open of trading on January 20, 2021. The new CUSIP number for the common stock will be 46265R103. \u00a0These changes follow the Company\u2019s announcement, in December 2020, of the successful completion of a share exchange transaction with I.R Med Ltd., an Israeli company, pursuant to which I.R Med Ltd became a wholly-owned subsidiary of the Company. Commenting on the actions, Limor Davidson &hellip; Continue reading \"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T13:26:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d","datePublished":"2021-01-20T13:26:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/"},"wordCount":477,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/","name":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==","datePublished":"2021-01-20T13:26:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEzODc2MyMzOTM3MjM3IzUwMDA3MDg4Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ir-med-inc-announces-finra-approval-of-name-change-and-ticker-symbol-change-to-irme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to \u201cIRME\u201d"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=417715"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417715\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=417715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=417715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=417715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}